These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 2907682)
21. Over-the-counter histamine2-blocker therapy. Gonzalez ER; Grillo JA Ann Pharmacother; 1994 Mar; 28(3):392-5. PubMed ID: 7910767 [TBL] [Abstract][Full Text] [Related]
22. Policy analysis of the conversion of histamine2 antagonists to over-the-counter use. Kalish SC; Bohn RL; Avorn J Med Care; 1997 Jan; 35(1):32-48. PubMed ID: 8998201 [TBL] [Abstract][Full Text] [Related]
23. The impact of H2-receptor antagonists on the complications, morbidity and mortality of peptic ulcer disease. Isenberg JI Aliment Pharmacol Ther; 1987; 1 Suppl 1():447S-454S. PubMed ID: 2908766 [TBL] [Abstract][Full Text] [Related]
24. Gastric acid suppressants--too much of a good thing? Logan IC; Sumukadas D; Witham MD Age Ageing; 2010 Jul; 39(4):410-1. PubMed ID: 20507846 [No Abstract] [Full Text] [Related]
25. Long-term therapy for reflux esophagitis. Tytgat GN N Engl J Med; 1995 Oct; 333(17):1148-50. PubMed ID: 7565956 [No Abstract] [Full Text] [Related]
26. Use of H2-receptor antagonists in patients with dyspepsia and heartburn: a cost comparison. Goulston KJ; Dent OF; Mant A; Logan J; Ngu M Med J Aust; 1991 Jul; 155(1):20-6. PubMed ID: 1676825 [TBL] [Abstract][Full Text] [Related]
27. [Treatment of peptic ulcer with histamine H2 receptor antagonists]. Domschke W; Domschke S; Demling L Fortschr Med; 1977 Aug; 95(31):1899-902. PubMed ID: 19347 [TBL] [Abstract][Full Text] [Related]
28. Clinical use of antacids. Halter F J Physiol Pharmacol; 1993 Sep; 44(3 Suppl 1):61-74. PubMed ID: 8260736 [TBL] [Abstract][Full Text] [Related]
29. Helicobacter pylori eradication ameliorates symptoms and improves quality of life in patients on long-term acid suppression. A large prospective study in primary care. Verma S; Giaffer MH Dig Dis Sci; 2002 Jul; 47(7):1567-74. PubMed ID: 12141818 [TBL] [Abstract][Full Text] [Related]
30. [Anti-H2 and omeprazole in brief therapy of peptic ulcer]. Piai G; Sabbatini F; Mazzacca G Ann Ital Chir; 1990; 61(1):11-4. PubMed ID: 1978622 [No Abstract] [Full Text] [Related]
31. [Self-medication in gastroesophageal reflux: role and limits]. De Winter B; Guillemot F Gastroenterol Clin Biol; 1999 Jan; 23(1 Pt 2):S297-301. PubMed ID: 10078459 [No Abstract] [Full Text] [Related]
32. The Effect of H Shim YK; Kim N Korean J Gastroenterol; 2017 Jul; 70(1):4-12. PubMed ID: 28728310 [TBL] [Abstract][Full Text] [Related]
34. Treatment of reflux esophagitis with histamine H2-receptor antagonists. Kishi S; Tsuzi Y; Matsumura M; Kakutani A; Ito S; Mori H Tokushima J Exp Med; 1985 Dec; 32(3-4):65-70. PubMed ID: 2875547 [No Abstract] [Full Text] [Related]
35. [Role of ranitidine in the treatment of gastroesophageal reflux and its complications]. Mainguet P Rev Med Suisse Romande; 1995 Oct; 115(10):781-8. PubMed ID: 7501930 [No Abstract] [Full Text] [Related]
39. Pharmacological bases of the medical treatment of gastroesophageal reflux disease. Scarpignato C Dig Dis; 1988; 6(3):117-48. PubMed ID: 2898983 [No Abstract] [Full Text] [Related]
40. Future trends in the management of peptic ulcer disease. Misiewicz JJ Scand J Gastroenterol Suppl; 1988; 146():175-84. PubMed ID: 2906462 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]